Online citations, reference lists, and bibliographies.
← Back to Search

A Single Dose Of Doxorubicin-functionalized Bow-tie Dendrimer Cures Mice Bearing C-26 Colon Carcinomas

C. Lee, E. Gillies, Megan E Fox, Steven J. Guillaudeu, J. Fréchet, Edward E Dy, F. Szoka
Published 2006 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The antitumor effect of doxorubicin (DOX) conjugated to a biodegradable dendrimer was evaluated in mice bearing C-26 colon carcinomas. An asymmetric biodegradable polyester dendrimer containing 8–10 wt % DOX was prepared. The design of the dendrimer carrier optimized blood circulation time through size and molecular architecture, drug loading through multiple attachment sites, solubility through PEGylation, and drug release through the use of pH-sensitive hydrazone linkages. In culture, dendrimer–DOX was >10 times less toxic than free DOX toward C-26 colon carcinoma cells after exposure for 72 h. Upon i.v. administration to BALB/c mice with s.c. C-26 tumors, dendrimer–DOX was eliminated from the serum with a half-life of 16 ± 1 h, and its tumor uptake was ninefold higher than i.v. administered free DOX at 48 h. In efficacy studies performed with BALB/c mice bearing s.c. C-26 tumors, a single i.v. injection of dendrimer–DOX at 20 mg/kg DOX equivalents 8 days after tumor implantation caused complete tumor regression and 100% survival of the mice over the 60-day experiment. No cures were achieved in tumor-implanted mice treated with free DOX at its maximum tolerated dose (6 mg/kg), drug-free dendrimer, or dendrimer–DOX in which the DOX was attached by means of a stable carbamate bond. The antitumor effect of dendrimer–DOX was similar to that of an equimolar dose of liposomal DOX (Doxil). The remarkable antitumor activity of dendrimer–DOX results from the ability of the dendrimer to favorably modulate the pharmacokinetics of attached DOX.
This paper references
J Bioact Compat Polym
La Mccormick-Thomson (1989)
Eur J Pharm Biopharm
J Kopecek (2000)
Cancer Res
M Yokoyama (1991)
10.1093/JNCI/77.2.459
Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration.
A. Gabizon (1986)
Cancer Res
C Dufès (2005)
Adv Drug Deliv Rev
K Ulbrich (2004)
10.1021/BC010102U
Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization.
H. Ihre (2002)
10.1016/S0168-3659(97)00115-6
Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor.
M. Yokoyama (1998)
OLP, Fréchet JMJ
H Ihre (2001)
10.1016/S0968-0896(99)00209-6
Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
P. Rodrigues (1999)
10.1016/S0168-3659(99)00133-9
Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.
K. Kataoka (2000)
Proc Natl Acad Sci
Sk Hobbs (1998)
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
S. Huang (1992)
Bioconjug Chem
Hr Ihre (2002)
Proc Natl Acad Sci USA
SK Hobbs (1998)
J Labelled Comp Radiopharm
Dj Larwood (1984)
10.1021/BC010103M
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation.
O. L. Padilla De Jesús (2002)
Cancer Res
Sk Huang (1992)
J Control Release
M Yokoyama (1998)
Cancer Res
Jf Kukowska-Latallo (2005)
10.1177/088391158900400303
Poly(amino acid) Copolymers as a Potential Soluble Drug Delivery System. 2. Body Distribution and Preliminary Biocompatibility Testing In Vitro and In Vivo
L. A. Mccormick-Thomson (1989)
10.1021/JA028100N
Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture.
E. Gillies (2002)
J Natl Cancer Inst
Eg Mayhew (1987)
10.1016/0142-9612(89)90075-6
Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro.
B. Říhová (1989)
10.1038/bjc.1994.363
Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.
L. Seymour (1994)
Am J Pathol
H Hashizume (2000)
J Control Release
N Malik (2000)
10.1016/S0169-409X(00)00124-1
Block copolymer micelles for drug delivery: design, characterization and biological significance.
K. Kataoka (2001)
10.1097/00001813-199909000-00010
Dendrimer-platinate: a novel approach to cancer chemotherapy.
N. Malik (1999)
Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
L. Gerweck (1996)
Adv Drug Deliv Rev
Rb Greenwald (2003)
J Am Chem Soc
Er Gillies (2002)
10.1016/J.ADDR.2003.10.040
Polymeric anticancer drugs with pH-controlled activation.
K. Ulbrich (2004)
Anticancer Drugs 10:767–776
N Malik (1999)
J Control Release
K Ulbrich (2003)
J Control Release
K Kataoka (2000)
J Am Chem Soc
H Ihre (2001)
10.1163/156856202320813846
Synthesis and biological properties of antitumor-active conjugates of ADR with dextran
Jan-An Guu (2002)
10.1038/nrd1088
The dawning era of polymer therapeutics
R. Duncan (2003)
Mol Pharm
Er Gillies (2005)
Clin Cancer Res
Pa Vasey (1999)
J Control Release
H Maeda (2000)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
Excretion and distribution studies in rats with two forms of 14carbon-labelled polyvinylpyrrolidone with a relatively low mean molecular weight after intravenous administration.
W. Hespe (1977)
10.1016/S1461-5347(99)00203-5
Designing dendrimers for drug delivery.
Liu (1999)
10.1093/JNCI/78.4.707
Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38.
E. Mayhew (1987)
OLP (2003) PhD dissertation (Univ of California, Berkeley)
De Jesús (2003)
10.1021/MP049886U
Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture.
E. Gillies (2005)
10.1158/0008-5472.CAN-04-3921
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
J. Kukowska-Latallo (2005)
10.1126/SCIENCE.1095833
Drug Delivery Systems: Entering the Mainstream
T. Allen (2004)
Biochem Pharmacol
Lw Seymour (1990)
OLP (2003) PhD dissertation (Univ of California, Berkeley)
De Jesús (2003)
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
M. Yokoyama (1991)
10.1016/S0169-409X(02)00180-1
Effective drug delivery by PEGylated drug conjugates.
R. Greenwald (2003)
Bioconjug Chem
De Jesús (2002)
10.1016/S1359-6446(04)03276-3
Dendrimers and dendritic polymers in drug delivery.
E. Gillies (2005)
Proc Natl Acad Sci
D Papahadjopoulos (1991)
Bioorg Med Chem
Pca Rodrigues (1999)
Nat Rev Drug Discov
Vp Torchilin (2005)
Fréchet JMJ (2005) Drug Discov Today 10:35–43
ER Gillies (2005)
Br. J. Cancer
M. Gerretsen (1993)
Cancer Res
Le Gerweck (1996)
Adv Exp Med Biol
B Ríhová (2003)
10.1007/978-3-540-38918-7_5140
[Anticancer drugs].
H. Fujita (1995)
Bioconjug Chem
M Pechar (2000)
Arzneim-Forsch
W Hespe (1977)
J Biomater Sci Polym Ed
Ja Guu (2002)
10.1016/S0168-3659(99)00246-1
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
N. Malik (2000)
10.1007/0-306-47932-X_8
Drug-HPMA-HuIg conjugates effective against human solid cancer.
B. Říhová (2003)
Www
Bioconjug Chem
H Maeda (1992)
Pharm Sci Technol Today
Mj Liu (1999)
10.1016/0006-2952(90)90293-T
The pharmacokinetics of polymer-bound adriamycin.
L. Seymour (1990)
Phase I Clinical and Pharmacokinetic Study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First Member of a New Class of Chemotherapeutic Agents—Drug-Polymer Conjugates
P. Vasey (1999)
10.1016/S0002-9440(10)65006-7
Openings between defective endothelial cells explain tumor vessel leakiness.
H. Hashizume (2000)
10.1016/S0939-6411(00)00075-8
HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action.
J. Kopeček (2000)
J Natl Cancer Inst
A Gabizon (1986)
Adv Drug Deliv Rev
K Kataoka (2001)
10.1073/PNAS.88.24.11460
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
D. Papahadjopoulos (1991)
10.1073/PNAS.95.8.4607
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.
S. Hobbs (1998)
10.1038/nbt1171
Designing dendrimers for biological applications
C. C. Lee (2005)
10.1021/JA010524E
Fast and convenient divergent synthesis of aliphatic ester dendrimers by anhydride coupling.
H. Ihre (2001)
Bioconjug Chem
T Kaneko (1991)
10.1021/BC00017A001
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.
H. Maeda (1992)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1016/S0168-3659(02)00348-6
HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
K. Ulbrich (2003)
Nat Rev Drug Discov
R Duncan (2003)
Adv Polym Sci
J Drobník (1984)
10.1007/3-540-12796-8_9
Soluble synthetic polymers in biological systems
J. Drobník (1984)
10.1158/0008-5472.CAN-04-4402
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
C. Dufès (2005)
C R Acad Sci Ser II
F Brochard-Wyart (1996)
10.1021/BC00009A001
New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
T. Kaneko (1991)
Nat Biotechnol
Cc Lee (2005)
De Jesús (2003)
Drug Discov Today
Er Gillies (2005)
Fréchet JMJ, Szoka FC (2005) Mol Pharm 2:129–138
ER Gillies (2005)
10.1021/BC990092L
Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin.
M. Pechar (2000)
10.1179/174328408x369933
Biomaterials
R. Misra (2008)
10.1002/JLCR.2580210703
Synthesis, characterization, and in vivo disposition of iodinatable polyethylene glycol derivatives: Differences in vivo as a function of chain length
D. Larwood (1984)



This paper is referenced by
Nanotecnología en la gastrohepatología
Yineth Agudelo Zapata (2008)
10.4155/TDE.10.22
Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.
H. Sarin (2010)
10.1021/nn301142r
Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates.
H. Dong (2012)
10.1007/978-3-319-09801-2_10
Nanotechnology to Combat Multidrug Resistance in Cancer
Sohail Akhter (2015)
10.1039/C5TB00623F
A polyphosphoester-conjugated camptothecin prodrug with disulfide linkage for potent reduction-triggered drug delivery.
Qingqing Zhang (2015)
10.1007/s13346-015-0270-y
The effect of particle shape and size on cellular uptake
Menglian Zheng (2015)
10.3390/ijms130911681
Cellular Delivery of Doxorubicin via pH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)
R. Patil (2012)
10.4172/2157-7439.1000519
Advances in delivery systems for doxorubicin.
N. Zhao (2018)
10.34133/2020/9301215
Bacterial Template Synthesis of Multifunctional Nanospindles for Glutathione Detection and Enhanced Cancer-Specific Chemo-Chemodynamic Therapy
Yan-Wen Bao (2020)
10.17352/2455-3492.000027
Nanoparticulate system for cancer therapy: An updated review
D. Kumar (2018)
Concise Encyclopedia of Biomedical Polymers and Polymeric Biomaterials Adhesives — Medical Devices and Preparative Medicine
R. Tong (2019)
10.1021/bm3018615
Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: a comparative study.
U. H. Sk (2013)
10.1021/bc1000033
Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.
J. Luo (2010)
10.1039/C1PY00179E
Targeted delivery of doxorubicin into cancer cells using a folic acid–dendrimer conjugate
Y. Wang (2011)
10.1039/C2NJ20849K
PEG-dendritic block copolymers for biomedical applications
A. Sousa-Hervés (2012)
10.1021/ja411457r
Oligo(ethylene glycol)-based thermosensitive dendrimers and their tumor accumulation and penetration.
Wei Wu (2014)
10.1039/C4TB00128A
A novel nanoassembled doxorubicin prodrug with a high drug loading for anticancer drug delivery.
Z. Xu (2014)
10.1021/bm5005788
Effect of Alkyl Length of Peptide–Polymer Amphiphile on Cargo Encapsulation Stability and Pharmacokinetics of 3-Helix Micelles
N. Dube (2014)
10.1039/C4TB01231C
Acid-triggered drug release from micelles based on amphiphilic oligo(ethylene glycol)-doxorubicin alternative copolymers.
Yeqiu Wang (2014)
10.1002/chem.201504605
Biodegradable Peptide-Silica Nanodonuts.
L. Maggini (2016)
10.1016/J.COSSMS.2013.01.001
Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide).
R. Tong (2012)
10.1016/j.biomaterials.2015.02.053
Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
F. Zhang (2015)
10.7150/thno.43092
Bioactive phospho-therapy with black phosphorus for in vivo tumor suppression
Shengyong Geng (2020)
10.1039/C1NJ20459A
Dendrimer therapeutics: covalent and ionic attachments
S. E. Kazzouli (2012)
10.1002/POLA.22525
Dendritic macromers for hydrogel formation: Tailored materials for ophthalmic, orthopedic, and biotech applications
M. Grinstaff (2008)
10.1002/POLA.23036
Block Copolymer Micelles Conjugated with anti-EGFR Antibody for Targeted Delivery of Anticancer Drug
Taiho Noh (2008)
10.1039/B817511J
Synthesis and In vitro activity of ROMP-based polymer nanoparticles.
D. Smith (2009)
10.1016/j.addr.2010.12.005
Prodrug-based intracellular delivery of anticancer agents.
L. Bildstein (2011)
10.1002/9780470767047.CH8
Biopolymer, Dendrimer, and Liposome Nanoplatforms for Optical Molecular Imaging
David Pham (2011)
10.1007/s11095-010-0339-8
Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
Wassana Wijagkanalan (2010)
10.1021/bm401471p
Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Y. Yu (2014)
10.1021/am504849x
Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fanfan Fu (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar